Dermatology, MOHS-Micrographic Surgery · Brooklyn, NY
NPI
1801813621
Since 2006
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
35 West End Avenue, Prof. Suite 2
Brooklyn, NY, 11235
Phone (718) 375-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
25,912 services
Medicare patients, 2024
2,183
Average age 79
Drug cost, 2024
$4.3M
9,525 prescriptions
Company payments, 2025
$1,622
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eyal K Levit was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 8,602 times for 25 patients. In total Eyal K Levit billed 25,912 services in 104 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 8,602 | 25 | $1.34 | $12K |
| 17003 Destruction Skin Lesion | Office | 5,246 | 589 | $6.37 | $33K |
| 99213 Office E&M - Established | Office | 3,132 | 1,372 | $84.61 | $265K |
| 17000 Destruction Skin Lesion | Office | 1,252 | 746 | $53.39 | $67K |
| 11102 Skin Biopsy | Office | 1,099 | 819 | $86.90 | $96K |
| 99214 Office E&M - Established | Office | 818 | 603 | $118.23 | $97K |
| 17004 Destruction Skin Lesion | Office | 763 | 400 | $161.13 | $123K |
| 17110 Destruction Skin Lesion | Office | 603 | 404 | $106.16 | $64K |
| 99212 Office E&M - Established | Office | 547 | 364 | $53.78 | $29K |
| Q4102 Oasis wound matrix, per square centimeter | Office | 471 | 12 | $9.57 | $4,507 |
| 99203 Office E&M - New | Office | 407 | 407 | $103.58 | $42K |
| 11103 Skin Biopsy | Office | 354 | 251 | $48.82 | $17K |
| 99202 Office E&M - New | Office | 213 | 213 | $63.19 | $13K |
| 17311 Mohs Surgery | Office | 202 | 173 | $656.73 | $133K |
| 96372 Injection Administration | Office | 184 | 31 | $13.56 | $2,495 |
By year: 2022 $1.1M for 14,334 services; 2023 $1.7M for 28,004 services; 2024 $1.6M for 25,912 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eyal K Levit prescribed most often to Medicare patients was Ketoconazole, with 1,239 prescriptions and refills. In total Eyal K Levit wrote 9,525 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 1,239 | 1,256 | 286 | $16K |
| Clotrimazole Generic | 650 | 657 | 267 | $7,249 |
| Halobetasol Propionate Generic | 605 | 612 | 459 | $33K |
| Mupirocin Generic | 432 | 434 | 291 | $2,310 |
| Diclofenac Sodium Generic | 405 | 461 | 209 | $49K |
| Ammonium Lactate Generic | 401 | 402 | 144 | $6,741 |
| Fluconazole Generic | 377 | 395 | 192 | $4,523 |
| Opzelura Ruxolitinib Phosphate | 339 | 340 | 148 | $670K |
| Ciclopirox Ciclopirox Olamine | 324 | 325 | 134 | $6,283 |
| Fluorouracil Generic | 244 | 249 | 177 | $20K |
| Cefdinir Generic | 227 | 227 | 195 | $2,341 |
| Silver Sulfadiazine Generic | 221 | 225 | 103 | $3,533 |
| Valacyclovir Valacyclovir Hcl | 216 | 224 | 120 | $4,001 |
| Nystatin Generic | 215 | 223 | 71 | $4,480 |
| Imiquimod Generic | 207 | 219 | 85 | $3,528 |
Brand drugs: - claims; generic drugs: 7,743 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eyal K Levit $1,622 ($1,622 in general payments such as food, travel and fees) from 19 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $223.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $223 |
| Arcutis Biotherapeutics, Inc. ARQT | 9 | $197 |
| LEO Pharma Inc. | 9 | $158 |
| Incyte Corporation INCY | 7 | $155 |
| Amgen Inc. AMGN | 7 | $145 |
| Mallinckrodt Hospital Products Inc. | 5 | $123 |
| Janssen Biotech, Inc. JNJ | 6 | $110 |
| Botanix SB Inc | 4 | $109 |
| Lilly USA, LLC LLY | 4 | $103 |
| Pfizer Inc. PFE | 3 | $66.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.